Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika

1 1 Senast ändrade genom HSLF-FS 2016:81.

HSLF-FS

ng – – – –

2017:1

rkni ä

Anm

g ionell

förtecknin – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – Internat N I – – N I P II –

Svensk förteckning

II I I II I I

– – – – – – – – – – – – – – – – – – – – – – – –

skt namn

N-dimetylmetanamin (pyrrolidin-1-yl)pentan-1-on

-dimetyltryptamin

Entydigt kemi

-acetoxi-N,N -1,3-dimetyl-4-fenyl-4-propionoxypiperidin 3-acetoxy-6-dimetylamino-4,4-difenylheptan 4 1-(6-fenyl-8-kloro-4H-[1,2,4]triazolo[4,3-a][1,4] bensodiazepin-1-yl)-N, α 1-fenyl-2-(pyrrolidin-1-yl)-pentan-1-on 1-(4-fluorofenyl)-2- Ämne – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

ra vanligt namn d n

rofenon A förekommande inazolam -PVP 4-AcO-DMT Ad α Alfa-pyrrolidino- vale 4F-alfa-PVP

INN-benämning

2 Acetylmetadol Alfaprodin – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

HSLF-FS

– – – – – – 2017:1

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – N I P II N I N I P IV N 1 P III – –

II I II II IV II II I I – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – orfan m

etylfenyl)-2-oxazolin

)-1,3-dihydro-1-metyl-7-nitro no-1,1-di(2'-tienyl)-1-buten nyl)-1-metyl-8-nitro-4H-

-(1-metyl-2-piperidinoetyl)propion-anilid 2-dimetylaminoetyl-1-etoxy-1,1-difenylacetat 2-amino-4-metyl-5-(4-m 3-dimetylami N 7-bromo-1,3-dihydro-5-(2-klorofenyl)-2H-1,4- bensodiazepin-2-on 2'-hydroxi-5,9-dimetyl-2-fenetyl-6,7-benso 5-(o-fluorofenyl 2H-1,4-bensodiazepin-2-on 6-(2-fluorofe [1,2,4]triazolo[4,3-a][1,4]bensodiazepin 4-fluoramfetamin – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

ex inor imetylaminolam y 4,4’-d rex Para-metyl-4- met 4,4’-DMAR Fenazepam Flunitrazolam

ol ad

Dimenox Dimetyltiambuten Fenampromid Fenazocin Flunitrazepam 3 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

HSLF-FS

2017:1 – – – – – –

Vissa bered- ningar N III

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – N II – N I – – N I N I P II –

III I II I I II II I

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – I ranu l]f y

in-4d eri p

ryloxyetyl)-4-fenylpiperidinmetyl-4,4-difenyl-3-hexanon fenyletyl)pi nyl)-2-(metylamino)propan-1-on 1-(2- -[ N

nyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2orfolinyletylmorfin fenyl- -(2-tetrahydrofurfu M N- 2-karboxamid 1 4-karboxylsyraetylester N-fe metylpropanamid 6-dimetylamino-5- 5-metyldihydromorfinon 2-(etylamino)-2-(3-metoxifenyl)cyklohexanon 1-(3-metoxife – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

butyrfentanyl Furanylfentanyl Fu-F Ibogain Iso Metoxetamin MXE 3-metoximetkatinon

4 Folkodin Furetidin Isometadon Metopon – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

HSLF-FS

– – – – – – 2017:1

V I – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – N – – P I P I

II I– I I I IV

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

rrolidin-1-yl)propan-1-on metyl)-1,3-dihydro-5-fenyldihydro-7-nitro-2H-1,4n fi or

ensylm b

istyl yr -(etylamino)-1-fenylbutan-1-on -(4-metylfenyl)-2-(py -kloro-1-(cyklopropyl M 5-(2-fluorofenyl)-1,3- bensodiazepin-2-on 2 1 4-metoxi-N-metylamfetamin 7 2H-1,4-bensodiazepin-2-on – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

P P P

N-desmetylflunitra- zepam N-etylbufedron p-Me PMMA 4-MMA Para-metoximet- amfetamin

in

Myrof Prazepam 5 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

HSLF-FS

2017:1 Dessa föreskrifter träder i kraft den 25 januari 2017. Läkemedelsverket CATARINA ANDERSSON FORSMAN Joakim Brandberg

HSLF-FS kan laddas ner via Läkemedelsverket. Webb: www.lakemedelsverket.se

Författningen kan beställas via: Wolters Kluwer 106 47 Stockholm Telefon: 08-598 191 90 Fax: 08-598 191 91 E-post: kundservice@wolterskluwer.se Webb: wolterskluwer.se/offentligapublikationer

Elanders Sverige AB, 2017